Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

429
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
429
Dementia01:30

Dementia

91
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
91
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

150
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
150
Longitudinal Studies01:26

Longitudinal Studies

120
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
120

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A lightweight network for segmenting tree-like structures in medical images.

Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society·2026
Same author

OCT-based optic neuropathy diagnosis using explainable and privacy-preserving machine learning.

Scientific reports·2026
Same author

Medical hierarchical image classification via dual-geometry image-text learning.

Medical image analysis·2026
Same author

Multiple attention based deep multimodal fusion network for glaucoma and neurodegenerative disease diagnosis.

Scientific reports·2026
Same author

Cognitive Load Measurement Methods for Usability Testing: A Critical Analysis and Framework for Interface Evaluation.

Human factors·2026
Same author

Dissecting appraisal and multicomponential features of emotion: Evidence from multilevel annotation during naturalistic stimulation.

Emotion (Washington, D.C.)·2026

Related Experiment Video

Updated: May 27, 2025

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K

Identifying risk factors for Alzheimer's disease from multivariate longitudinal clinical data using temporal pattern

Annette Spooner1, Gelareh Mohammadi2, Perminder S Sachdev3

  • 1School of Computer Science and Engineering, UNSW Sydney, Sydney, Australia. a.spooner@unsw.edu.au.

BMC Bioinformatics
|February 18, 2025
PubMed
Summary

We developed Clinical Temporal Pattern Mining (C-TPM), an efficient framework for analyzing complex patient data. C-TPM identifies high-risk temporal patterns predictive of diseases like Alzheimer's, aiding early detection and understanding disease progression.

Keywords:
Clinical dataRelative riskSurvival analysisTemporal abstractionTemporal pattern mining

More Related Videos

Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.8K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

940

Related Experiment Videos

Last Updated: May 27, 2025

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.8K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

940

Area of Science:

  • Computational biology
  • Data science
  • Medical informatics

Background:

  • Clinical data presents challenges for modeling due to heterogeneity and varied time series.
  • Existing temporal pattern mining algorithms are not optimized for complex clinical datasets.
  • Understanding disease onset and progression requires effective modeling of longitudinal patient information.

Purpose of the Study:

  • To introduce an efficient and scalable framework, Clinical Temporal Pattern Mining (C-TPM), for temporal pattern mining of real-world clinical data.
  • To identify clinically relevant and high-risk temporal patterns from multivariate, longitudinal patient data.
  • To improve the computational efficiency and interpretability of clinical data analysis.

Main Methods:

  • Developed C-TPM, integrating temporal abstraction, an extended TPMiner algorithm, relative risk, odds ratio, and multiprocessing.
  • Applied a complete set of cut-off values for data discretization and interpretation.
  • Utilized a visualization module for clear pattern representation.

Main Results:

  • Applied C-TPM to Alzheimer's disease (AD) datasets, discovering patterns predictive of AD.
  • Achieved a high Concordance index (up to 0.87) in survival analysis models using discovered patterns.
  • Identified clinically relevant variables within the discovered temporal patterns.

Conclusions:

  • C-TPM offers an effective and scalable method for modeling complex longitudinal clinical data.
  • The framework can identify patterns in rare or slowly progressing diseases.
  • C-TPM is generalizable to various medical and non-clinical data domains.